Literature DB >> 36038752

A case of malignant nephrosclerosis occurring with serum renin in the normal range.

Masato Sawamura1, Naoki Sawa1,2, Yoichi Oshima1, Daisuke Ikuma1, Masayuki Yamanouchi1, Noriko Hayami1, Akinari Sekine1, Hiroki Mizuno1, Eiko Hasegawa1, Tatsuya Suwabe1,2, Junichi Hoshino1,2, Kei Kono3, Keiichi Kinowaki3, Kenichi Ohashi3,4, Yoshifumi Ubara5,6.   

Abstract

A 37-year-old Japanese man was admitted to our hospital for evaluation of severe hypertension and visual impairment. His serum creatinine was 4.16 mg/dL. Plasma renin activity was normal (2.7 ng/mL/h), but plasma aldosterone concentration was elevated (27.2 ng/dL). A kidney biopsy showed concentric subendothelial edematous thickening of the arterioles (onion skin pattern) with luminal narrowing or obstruction, and malignant nephrosclerosis was diagnosed. Antihypertensive therapies, including an angiotensin II receptor blocker and spironolactone, were administered and effectively preserved kidney function and normalized blood pressure. This case indicates that hyperaldosteronemia in the presence of normal renin levels might also cause malignant hypertension.
© 2022. The Author(s) under exclusive licence to The Japan Society of Nephrology.

Entities:  

Keywords:  Hyperaldosteronemia; Hyperaldosteronism; Hypertensive emergency; Malignant hypertension; Malignant nephrosclerosis; Renin-angiotensin system

Year:  2022        PMID: 36038752     DOI: 10.1007/s13730-022-00726-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  2 in total

1.  Renin‑secreting juxtaglomerular cell tumor of the kidney causing severe hypertension and polyuria.

Authors:  Aleksander Prejbisz; Artur A Antoniewicz; Marek Kabat; Jacek Kuroszczyk; Maria Stelmachowska-Banaś; Andrzej Januszewicz
Journal:  Pol Arch Med Wewn       Date:  2014-02-20

Review 2.  Malignant hypertension: new aspects of an old clinical entity.

Authors:  Andrzej Januszewicz; Tomasz Guzik; Aleksander Prejbisz; Tomasz Mikołajczyk; Grzegorz Osmenda; Włodzimierz Januszewicz
Journal:  Pol Arch Med Wewn       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.